Editorial: Advanced nanotechnology for reactive oxygen species-mediated therapies. 2022

Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
Department of Biomedical Engineering, SKKU Institute for Convergence, Sungkyunkwan University, Suwon, South Korea.

UI MeSH Term Description Entries

Related Publications

Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
April 2022, Antioxidants & redox signaling,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
November 2016, Life sciences,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
September 2017, Chemical record (New York, N.Y.),
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
January 2022, Frontiers in cardiovascular medicine,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
February 2024, Biochimica et biophysica acta. Molecular basis of disease,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
June 2004, Biomedical microdevices,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
January 2024, Frontiers in immunology,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
January 2022, Anti-cancer agents in medicinal chemistry,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
July 1994, Free radical research,
Chun Gwon Park, and Wonhaw Lee, and Dong-Hyun Kim, and Fangyuan Li, and Wooram Park
January 2023, Frontiers in cell and developmental biology,
Copied contents to your clipboard!